Laserfiche WebLink
• <br />• <br />"Set:!Jjp Forms" 1040010ift standard tla t6insar ' &icummrt oW 1M which who compl ti ani <br />signed by or Client (electronic communications from Client indicating t'a approval tla Set -V PA* <br />shall satisfy the foregoing), w describe the essential elements adopted by i%l ent for its 11%scri . <br />Program,, ► , coverage and benefit designs, and clinical and trill prd <br />i <br />may be amended byCHent from time ta'tima, <br />"Single Source Prod uceloopis Ik fitedication that is: (i) approved byt ft,under a ge> <br />drug ANDA application and is licensed and then currently marketed by only one genera drug manufact <br />under separate ANDA applications; or (ii) subject to patent litigation. <br />"S 1& Product List" (for those Clients that are non-&dlusive) means tits standard list of <br />Products and their reimbursement rates under the applicable (exclusive or open) option, maintBitMft. <br />updated*- from time to time. The SpecislW i3ttvailablti W upon reque6t. <br />"Specialty Ptoducts" means those injectable and note injectable drugs on the Specialty ftoftt LM. <br />Specialty Products typically have one or more of severalis characteristics, including frame dosing <br />j adjustments and intensive clinical monitoring to decrease the potential for drug toxicity and increase the <br />j probability for beneficial treatment outcomes; intensive patient training and compliance assistance to <br />facilitate therapeutic, VNW Wtexclusiva:poba.availability arkution; specialized.p <br />handling and/or administration requirements and/orptist n excess of $30$x,30 day supply. <br />"Subroeation Claim" means subrogation claims submitted byAW state or a persoltw-1tal � rlt l <br />of a state under Medicaid or similar United States or state government health care promsCt <br />p or n of licable federal or state laws, r <br />is deemed to be the ritnary pay by 4per app <br />"Term" sha4lon lel t,*w period between die'1111#9 jtIiiarand termination of this Agreement, including <br />the Initial T extertmd b an Renewal s are defined in Article VLA). <br />s <br />Y y # > <br />i "Usual and Customary Price"' or"; ",tttdertallism price charged by Partkip�harmacy for tbo f <br />particular drug in a cash transaction on th+e Il is lltia +M dispensed as mpoded to <br />Pharmacy. <br />A19(:3i,E n — ARMAtli1TR1TIVE SERVICES f <br />AAministraW shall administer the prescription drug benefits Pit ltrtt layiiQbw Mn, subject to all of <br />the terms and conditions of this Agreement, as the same:y#dtttrti B'tttttatlme to°time. <br />It., : Atlfnw►istrmrer shall provide such assistance as may reasonalll�t necessary to Client's personnel in <br />enrollment d eligible employees and former employees A14 dt3pendents eligible under the Plan. <br />AdministriiWshalt maintain up-to-date eligibil(fy status records on all enrolled Members as submitted by <br />Client for purposes of appropriate adjudication.of Prescription Drug Claims under the Plan. <br />C: Administrator shall issue (or cause to be issued presm*"Arug cards to each Member -employee who is <br />enrolled ip Ynrt'a Plan and who is declared eligible b (1004 as evidence of such Member employee's <br />erttidement to prescription drug card benefits under tbefim <br />11 Upon reasonable request, Administrator 1ft Client with costs projections and analyses of <br />Fyescription Drug Claims and such other statistical data as may reasonably be requested bdant `in <br />{ <br />connection with Client's management, oversight and control ckfoo Plan. <br />E. Administrattg' shall invoice Coot 'fm` f Prescription Drug Clebris due to be pw'"COO OWWj <br />Prescription Drug Claims du .;plus monthly Transaction fees and any other fees payabia• ly t <br />Article IV hereof and/or the A"Wation � <br />1141" FOR D1STRIBUTi 1.VO <br />AND NSTITUM <br />7 lltil ilii i� <br />A <br />80 <br />